Literature DB >> 6950413

Marfan syndrome: abnormal alpha 2 chain in type I collagen.

P H Byers, R C Siegel, K E Peterson, D W Rowe, K A Holbrook, L T Smith, Y H Chang, J C Fu.   

Abstract

Cells in culture from a woman with a variety of the Marfan syndrome produce two species of the alpha 2 chains of type I collagen. One alpha 2 chain appears normal; the abnormal chain has a higher apparent molecular weight than normal and migrates more slowly during electrophoresis in sodium dodecyl sulfate/polyacrylamide gels. A similar change in electrophoretic behavior is seen in the prepro alpha 2 chain and the pN alpha 2 chain (which contains the amino-terminal extension). Asymmetric cleavage of the pepsin-treated procollagens with a fibroblast collagenase locates the abnormal segment amino terminal to the cleavage site, and analysis of cyanogen bromide peptides of collagenase cleavage peptides and of whole collagens indicates that the abnormal segment is in either the alpha 2CB3 peptide or the short segment of alpha 2CB5 amino terminal to the collagenase site of the altered alpha 2 chain. The higher apparent molecular weight is consistent with the insertion of a small peptide fragment of approximately 20 amino acids. This alteration in chain size has marked effects on crosslinking because collagen from the patient's skin was 5-10 times more extractable in nondenaturing solvents than that from control skins. Although the abnormal chain was not found in several other individuals with the Marfan syndrome, these findings suggest that the phenotype may be the expression of a variety of primary structure alterations in the chains of type I collagen that interfere with normal crosslink formation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6950413      PMCID: PMC349347          DOI: 10.1073/pnas.78.12.7745

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Scoliosis and dissecting aneurysm of the aorta in rats fed with Lathyrus odoratus seeds.

Authors:  I V PONSETI; W A BAIRD
Journal:  Am J Pathol       Date:  1952 Nov-Dec       Impact factor: 4.307

2.  The marfan's syndrome. In vitro study of collagen metabolism in tissue specimens of the aorta.

Authors:  T Krieg; P K Müller
Journal:  Exp Cell Biol       Date:  1977

Review 3.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

4.  Letter: Collagen of Marfan syndrome is abnormally soluble.

Authors:  R E Priest; J F Moinuddin; J H Priest
Journal:  Nature       Date:  1973-10-05       Impact factor: 49.962

5.  Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.

Authors:  A Vogel; K A Holbrook; B Steinmann; R Gitzelmann; P H Byers
Journal:  Lab Invest       Date:  1979-02       Impact factor: 5.662

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Collagen metabolism of the skin in Marfan's syndrome.

Authors:  O Laitinen; J Uitto; M Iivanainen; M Hannuksela; K I Kivirikko
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

9.  NH2-terminal sequence of the chick proalpha1(I) chain synthesized in the reticulocyte lysate system. Evidence for a transient hydrophobic leader sequence.

Authors:  R D Palmiter; J M Davidson; J Gagnon; D W Rowe; P Bornstein
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

Review 10.  Lysyl oxidase.

Authors:  R C Siegel
Journal:  Int Rev Connect Tissue Res       Date:  1979
View more
  37 in total

1.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

2.  Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene.

Authors:  K Kainulainen; B Steinmann; F Collins; H C Dietz; C A Francomano; A Child; M W Kilpatrick; D J Brock; M Keston; R E Pyeritz
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

3.  Linkage data for Marfan syndrome and markers on chromosomes 1 and 11.

Authors:  J de Groote; P A Farndon; M V Kilpatrick; A de Paepe; J W Oorthuys; N C Nevin; A H Child; F M Pope
Journal:  J Med Genet       Date:  1990-02       Impact factor: 6.318

4.  Linkage analysis in Marfan syndrome.

Authors:  R C Schwartz; S H Blanton; C A Hyde; T R Sottile; L Hudgins; M Sarfarazi; P Tsipouras
Journal:  J Med Genet       Date:  1990-02       Impact factor: 6.318

5.  Marfan syndrome: light at the end of the tunnel?

Authors:  P Tsipouras
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

Review 6.  Prenatal diagnosis and prevention of inherited abnormalities of collagen.

Authors:  F M Pope; S C Daw; P Narcisi; A R Richards; A C Nicholls
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Aortic root dilatation associated with partial trisomy 7(q31.2----qter).

Authors:  K B Roche; J W Moore; R B Surana; B E Wilson
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

8.  Pulmonary hyperinflation and emphysema in infants with the Marfan syndrome.

Authors:  R Dominguez; R A Weisgrau; M Santamaria
Journal:  Pediatr Radiol       Date:  1987

9.  Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.

Authors:  P H Byers; J R Shapiro; D W Rowe; K E David; K A Holbrook
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  The borohydride-reducible compounds of human aortic elastin. Demonstration of a new cyclic amino acid in alkali hydrolysate, and changes with age and in patients with annulo-aortic ectasia including one with Marfan syndrome.

Authors:  T Halme; M Jutila; T Vihersaari; P Oksman; N D Light; R Penttinen
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.